Linking RAGE and Nox in diabetic micro- and macrovascular complications

被引:82
作者
Koulis, C. [1 ,2 ]
Watson, A. M. D. [1 ,2 ]
Gray, S. T. [1 ,2 ]
Jandeleit-Dahm, K. A. [1 ,2 ]
机构
[1] Baker IDI Heart & Diabet Res Inst, Diabet Complicat Div, Melbourne, Vic 8008, Australia
[2] Monash Univ, Dept Med, Cent Clin Sch, Melbourne, Vic 3004, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Diabetes mellitus; Vascular complications; Atherosclerosis; Nephropathy; Oxidative stress; NADPH oxidases; Glycation; RAGE; GLYCATION END-PRODUCTS; NITRIC-OXIDE SYNTHASE; TISSUE GROWTH-FACTOR; NADPH OXIDASE; OXIDATIVE STRESS; ATHEROSCLEROTIC PLAQUES; NONENZYMATIC GLYCATION; NAD(P)H OXIDASE; RECEPTOR RAGE; MOUSE MODEL;
D O I
10.1016/j.diabet.2015.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes-associated micro- and macrovascular complications contribute to the increased morbidity and mortality observed in diabetes. Diabetes leads to accelerated generation of advanced glycation end products (AGEs) and activation of their receptor, RAGE, as well as activation of NAD(P)H oxidase (Nox), an enzyme dedicated to the production of reactive oxygen species, which ultimately leads to a pro-inflammatory environment characterised by oxidative stress. This review outlines the current evidence about the contribution of and interaction between the AGE-RAGE axis and Nox derived ROS formation in the development and progression of micro- and macrovascular diabetic complications (especially in atherosclerosis and nephropathy), and the mechanisms by which this occurs. We also outline novel treatments targeting the AGE-RAGE axis and specific Nox isoforms, which hold great promise in attenuating the development of diabetes-associated atherosclerosis and diabetic nephropathy. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:272 / 281
页数:10
相关论文
共 102 条
[1]   RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses [J].
Akirav, Eitan M. ;
Preston-Hurlburt, Paula ;
Garyu, Justin ;
Henegariu, Octavian ;
Clynes, Raphael ;
Schmidt, Marie ;
Herold, Kevan C. .
PLOS ONE, 2012, 7 (04)
[2]   Classical Inhibitors of NOX NAD(P) H Oxidases Are Not Specific [J].
Aldieri, Elisabetta ;
Riganti, Chiara ;
Polimeni, Manuela ;
Gazzano, Elena ;
Lussiana, Cristina ;
Campia, Ivana ;
Ghigo, Dario .
CURRENT DRUG METABOLISM, 2008, 9 (08) :686-696
[3]  
Aoyama T, 2012, HEPATOLOGY
[4]   Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products [J].
Beisswenger, Paul J. ;
Howell, Scott K. ;
Russell, Gregory B. ;
Miller, Michael E. ;
Rich, Stephen S. ;
Mauer, Michael .
DIABETES CARE, 2013, 36 (10) :3234-3239
[5]   Subcellular localization of Nox4 and regulation in diabetes [J].
Block, Karen ;
Gorin, Yves ;
Abboud, Hanna E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) :14385-14390
[6]   Reduction of Advanced-Glycation End Products Levels and Inhibition of RAGE Signaling Decreases Rat Vascular Calcification Induced by Diabetes [J].
Brodeur, Mathieu R. ;
Bouvet, Celine ;
Bouchard, Sonia ;
Moreau, Simon ;
Leblond, Jeanne ;
deBlois, Denis ;
Moreau, Pierre .
PLOS ONE, 2014, 9 (01)
[7]   RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].
Bucciarelli, LG ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Lalla, E ;
Rong, LL ;
Goova, MT ;
Moser, B ;
Kislinger, T ;
Lee, DC ;
Kashyap, Y ;
Stern, DM ;
Schmidt, AM .
CIRCULATION, 2002, 106 (22) :2827-2835
[8]   Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study [J].
Burke, AP ;
Kolodgie, FD ;
Zieske, A ;
Fowler, DR ;
Weber, DK ;
Varghese, PJ ;
Farb, A ;
Virmani, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1266-1271
[9]   Effect of TTP488 in patients with mild to moderate Alzheimer's disease [J].
Burstein A.H. ;
Grimes I. ;
Galasko D.R. ;
Aisen P.S. ;
Sabbagh M. ;
Mjalli A.M.M. .
BMC Neurology, 14 (1)
[10]   Advanced glycation end-products and the kidney [J].
Busch, Martin ;
Franke, Sybille ;
Ruester, Christiane ;
Wolf, Gunter .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (08) :742-755